REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc. (Nasdaq: RVPH) is a clinical-stage biopharmaceutical company focused on central nervous system disorders, including schizophrenia and major depressive disorder, that entered public markets through a special purpose acquisition company transaction in 2020. The company filed an 8-K with the U.S. Securities and Exchange Commission on December 18, 2020, reporting a material corporate event tied to the completion of its de-SPAC business combination. RVPH operates in the healthcare and life sciences sector and trades on the Nasdaq Capital Market. For full filing history, sponsor details, and deal analytics on RVPH and the broader SPAC universe, sign up for complete data access at SpacDesk.